Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Am J Drug Alcohol Abuse ; 49(6): 756-765, 2023 11 02.
Artículo en Inglés | MEDLINE | ID: mdl-37737714

RESUMEN

Background: Currently, the capacity to provide buprenorphine treatment (BT) is not sufficient to treat the growing number of people in the United States with opioid use disorder (OUD). We sought to examine participant retention in care rates of primary care delivered BT programs and to describe factors associated with retention/attrition for participants receiving BT in this setting.Objectives: A PRISMA-guided search of various databases was performed to identify the articles focusing on efficacy of BT treatment and OUD.Method: A systematic literature search identified 15 studies examining retention in care in the primary care setting between 2002 and 2020. Random effects meta-regression were used to identify retention rates across studies.Results: Retention rates decreased across time with a mean 0.52 rate at one year. Several factors were found to be related to retention, including: race, use of other drugs, receipt of counseling, and previous treatment with buprenorphine.Conclusions: While we only investigate BT through primary care, our findings indicate retention rates are equivalent to the rates reported in the specialty care literature. More work is needed to examine factors that may impact primary care delivered BT specifically and differentiate participants that may benefit from care delivered in specialty over primary care as well as the converse.


Asunto(s)
Buprenorfina , Trastornos Relacionados con Opioides , Humanos , Estados Unidos , Buprenorfina/uso terapéutico , Tratamiento de Sustitución de Opiáceos , Trastornos Relacionados con Opioides/tratamiento farmacológico , Trastornos Relacionados con Opioides/complicaciones , Resultado del Tratamiento , Atención Primaria de Salud , Analgésicos Opioides/uso terapéutico
2.
J Prim Care Community Health ; 14: 21501319221147246, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36625264

RESUMEN

BACKGROUND: Increases in fatal synthetic opioid overdoses over the past 8 years have left states scrambling for effective means to curtail these deaths. Many states have implemented policies and increased service capacity to address this rise. To better understand the effectiveness of policy level interventions we estimated the impact of the presence of naloxone access laws (NALs) on synthetic opioid fatalities at the state level. METHODS: A multivariable longitudinal linear mixed model with a random intercept was used to determine the relationship between the presence of NALs and synthetic opioid overdose death rates, while controlling for, Good Samaritan laws, opioid prescription rate, and capacity for medication for opioid use disorder (MOUD), utilizing a quadratic time trajectory. Data for the study was collected from the National Vital Statistics System using multiple cause-of-death mortality files linked to drug overdose deaths. RESULTS: The presence of an NAL had a significant (univariate P-value = .013; multivariable p-value = .010) negative relationship to fentanyl overdose death rates. Other significant controlling variables were quadratic time (univariate and multivariable P-value < .001), MOUD (univariate P-value < .001; multivariable P-value = .009), and Good Samaritan Law (univariate P-value = .033; multivariable P-value = .018). CONCLUSION: Naloxone standing orders are strongly related to fatal synthetic opioid overdose reduction. The effect of NALs, MOUD treatment capacity, and Good Samaritan laws all significantly influenced the synthetic opioid overdose death rate. The use of naloxone should be a central part of any state strategy to reduce overdose death rate.


Asunto(s)
Sobredosis de Droga , Sobredosis de Opiáceos , Trastornos Relacionados con Opioides , Humanos , Naloxona/uso terapéutico , Analgésicos Opioides/uso terapéutico , Sobredosis de Opiáceos/tratamiento farmacológico , Sobredosis de Opiáceos/epidemiología , Sobredosis de Droga/tratamiento farmacológico , Trastornos Relacionados con Opioides/tratamiento farmacológico
3.
Inquiry ; 58: 469580211017666, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34027712

RESUMEN

There is growing evidence that pre-exposure prophylaxis (PrEP) prevents HIV acquisition. However, in the United States, approximately only 4% of people who could benefit from PrEP are currently receiving it, and it is estimated only 1 in 5 physicians has ever prescribed PrEP. We conducted a scoping review to gain an understanding of physician-identified barriers to PrEP provision. Four overarching barriers presented in the literature: Purview Paradox, Patient Financial Constraints, Risk Compensation, and Concern for ART Resistance. Considering the physician-identified barriers, we make recommendations for how physicians and students may work to increase PrEP knowledge and competence along each stage of the PrEP cascade. We recommend adopting HIV risk assessment as a standard of care, improving physician ability to identify PrEP candidates, improving physician interest and ability in encouraging PrEP uptake, and increasing utilization of continuous care management to ensure retention and adherence to PrEP.


Asunto(s)
Fármacos Anti-VIH , Infecciones por VIH , Médicos , Profilaxis Pre-Exposición , Estudiantes de Medicina , Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/prevención & control , Humanos , Estados Unidos
4.
Prev Med Rep ; 20: 101184, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32995141

RESUMEN

Opioid overdose fatalities include deaths from natural opioids (morphine and codeine), semi-synthetic opioids (oxycodone, hydrocodone), synthetic opioids (prescription and illicit fentanyl, tramadol), methadone, and heroin. From 1999 to 2017, there were 702,568 drug overdose deaths in the U.S., with 399,230 attributed to opioids. This study aimed to assess the dynamics of opioid related fatalities throughout the U.S. from 2006-2016. This study is a secondary analysis of data obtained through the Kaiser Family Foundation's analysis of Centers for Disease Control and Prevention data, 1999-2016. The data obtained were from all 50 states and the District of Columbia. A total of 272,130 individuals were included in the analysis. This represents the number of opioid overdose deaths in the United States from 2006-2016. Descriptive analysis of overall rates was conducted and mapped for visualization. Novel predictive models of increase for each drug overdose category were developed and used to calculate rate changes. Finally, the elasticity of change in rate for each drug category was calculated annually for the past 11 years. The highest rate of opioid overdose-related death occurred in West Virginia (40.03 per 100,000). In our secondary analysis, we explored the change in the rate of opioid-related deaths from 2015 to 2016. The changing dynamics of fatal opioid overdose at the state level is critical to guiding policy makers in addressing this crisis. Rates of fatal opioid overdose vary across the states, but we identify some trends. Regional differences are identified in states with the highest overdose rates from all opioids combined.

5.
Soc Work Public Health ; 31(7): 678-687, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27366988

RESUMEN

The past decade has seen a marked increase in the illicit use of opioids, as well as a doubling of the percentage of individuals seeking treatment for opioid use disorders. However, little is known about the differences between opioid users and nonopioid users in residential treatment. Further, no studies have been published that compare opioid users and nonopioid users in treatment for co-occurring substance use and mental disorders. To address this gap, this study examined differences between opioid and nonopioid substance users in residential treatment for co-occurring disorders. Data was drawn from 1,972 individuals treated between 2009 and 2011 at one of three private residential treatment centers that provide integrated treatment for co-occurring substance use and mental disorders. Data was collected at program intake, and 1- and 6-month postdischarge using the Addiction Severity Index and the University of Rhode Island Change Assessment. To examine within-group changes in substance use, addiction severity, and mental health across time, linear mixed-model analyses were conducted with facility, year, age, gender, and race included as covariates. The authors found more similarities than differences between the two groups on baseline characteristics, treatment motivation, length of stay, and outcomes on measures of substance use, addiction severity, and mental health. The results demonstrate that though opioid users entered treatment with higher levels of substance use-related impairment, they were just as successful in treatment outcomes as their non-opioid-using peers.


Asunto(s)
Comorbilidad , Trastornos Mentales , Trastornos Relacionados con Opioides , Tratamiento Domiciliario , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Estados Unidos , Adulto Joven
6.
J Dual Diagn ; 11(1): 75-82, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25531670

RESUMEN

OBJECTIVE: The purpose of this study was to examine differences between older and younger adults who received integrated treatment for co-occurring substance use and mental disorders, including differences on demographic and baseline characteristics (e.g., substance use, readiness for change, mental health symptoms, and severity of problems associated with substance use), as well as predictors of retention in treatment. METHODS: This study included 1400 adults who received integrated substance abuse and mental health treatment services at one of two private residential facilities offering residential and outpatient services. Initial analyses consisted of basic descriptive and bivariate analyses to examine differences between older (≥ 50 years old) and younger (< 50 years old) adults on baseline variables. Next, three ordinary least squares regression models were employed to examine the influence of baseline characteristics on length of stay. RESULTS: Three main findings emerged. First, older adults differed from younger adults on pre-treatment characteristics. Older adults used more alcohol and experienced greater problem severity in the medical and alcohol domains, while younger adults used more illicit drugs (e.g., heroin, marijuana, and cocaine) and experienced problems in the drug, legal, and family/social domains. Second, while readiness to change did not differ between groups at baseline, older adults remained enrolled in treatment for a shorter period of time (nearly four days on average) than younger adults. Third, the pattern of variables that influenced length of stay in treatment for older adults differed from that of younger adults. Treatment retention for older adults was most influenced by internal factors, like psychological symptoms and problems, while younger adults seemed influenced primarily by external factors, like drug use, employment difficulties, and readiness for change. CONCLUSIONS: The results of this study add to the limited knowledge base regarding older adults receiving integrated treatment for co-occurring substance use and mental health disorders by documenting that age-based differences exist in general and in the factors that are associated with the length of stay in residential treatment.


Asunto(s)
Trastornos Mentales/epidemiología , Trastornos Mentales/terapia , Trastornos Relacionados con Sustancias/epidemiología , Trastornos Relacionados con Sustancias/terapia , Factores de Edad , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tratamiento Domiciliario/estadística & datos numéricos , Resultado del Tratamiento
7.
J Addict Nurs ; 25(4): 204-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25514691

RESUMEN

An increasing number of Americans are experiencing sleep problems. There is evidence of a complex, bidirectional relationship between sleep disorders, substance abuse, and mental health symptoms. Institutional settings have been shown to elicit sleep problems as well. This pilot study was conducted with 28 patients in private, residential, dual-diagnosis treatment for addiction and mental health disorders. Upon admission, consenting patients were administered the Addiction Severity Index to assess pretreatment substance use and mental health symptoms. Patients followed a normal course of treatment as well as participated in a nightly sleep hygiene group that included relaxation suggestions. Evaluations with the Addiction Severity Index were completed again 30 days after discharge from treatment. Significant improvements in some substance use patterns as well as mental health symptoms were noted. Although results cannot be directly attributed to the use of a sleep hygiene group, this pilot study lays the foundation for future investigations of interventions supporting sleep in the dual-diagnosis population.


Asunto(s)
Pacientes Internos , Trastornos Mentales/rehabilitación , Sueño , Trastornos Relacionados con Sustancias/rehabilitación , Adulto , Comorbilidad , Femenino , Conductas Relacionadas con la Salud , Humanos , Masculino , Trastornos Mentales/complicaciones , Trastornos Mentales/enfermería , Centros de Tratamiento de Abuso de Sustancias , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/enfermería , Resultado del Tratamiento
8.
J Psychoactive Drugs ; 45(2): 122-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23909000

RESUMEN

A significant number of individuals with co-occurring substance abuse and mental health disorders do not engage, stay, and/or complete residential treatment. The purpose of this study is to identify factors during the initial phase of treatment which predict retention in private residential treatment for individuals with co-occurring substance use and mental health disorders. The participants were 1,317 individuals with co-occurring substance abuse and mental health disorders receiving treatment at three residential treatment centers located in Memphis, TN, Malibu, CA, and Palm Springs, CA. Bivariate analysis and logistic regression were utilized to identify factors that predict treatment retention at 30 days. The findings indicate a variety of factors including age, gender, types of drug, Addiction Severity Index Medical and Psychiatric scores, and readiness to change. These identified factors could be incorporated into pretreatment assessments, so that programs can initiate preventive measures to decrease attrition and improve treatment outcomes.


Asunto(s)
Conductas Relacionadas con la Salud , Conocimientos, Actitudes y Práctica en Salud , Trastornos Mentales/psicología , Aceptación de la Atención de Salud , Pacientes Desistentes del Tratamiento/psicología , Instituciones Residenciales , Centros de Tratamiento de Abuso de Sustancias , Trastornos Relacionados con Sustancias/rehabilitación , Adulto , Factores de Edad , Comorbilidad , Femenino , Humanos , Tiempo de Internación , Modelos Logísticos , Masculino , Trastornos Mentales/diagnóstico , Trastornos Mentales/epidemiología , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Aceptación de la Atención de Salud/estadística & datos numéricos , Pacientes Desistentes del Tratamiento/estadística & datos numéricos , Práctica Privada , Instituciones Residenciales/estadística & datos numéricos , Medición de Riesgo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Factores Sexuales , Factores Socioeconómicos , Centros de Tratamiento de Abuso de Sustancias/estadística & datos numéricos , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/epidemiología , Trastornos Relacionados con Sustancias/psicología , Factores de Tiempo , Resultado del Tratamiento , Estados Unidos , Adulto Joven
9.
Soc Work Public Health ; 28(2): 109-18, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23461346

RESUMEN

Active substance users have been characterized as ambivalent about accessing treatment services. Few studies have addressed the social context and related barriers that individuals experience in addressing substance abuse problems. These barriers appear to be heightened for female methamphetamine users living in rural areas of Appalachia. The purpose of this study is to document the willingness of active female methamphetamine users to access substance abuse treatment services, their ability to access substance abuse treatment services, and the barriers they experienced in accessing substance abuse treatment services. Findings from a sample of 153 rural female methamphetamine users revealed the majority of respondents met the criteria for substance dependence (99.3%), believed they had a drug problem (84.9%), believed they needed treatment services (62.9%), and wanted to go to treatment "now" (51.4%). However, only one fourth (26.8%) had accessed treatment, and many had experienced barriers in attempting to enter treatment services.


Asunto(s)
Trastornos Relacionados con Anfetaminas/psicología , Accesibilidad a los Servicios de Salud , Necesidades y Demandas de Servicios de Salud , Disparidades en Atención de Salud/etnología , Aceptación de la Atención de Salud/psicología , Población Rural/estadística & datos numéricos , Adolescente , Adulto , Trastornos Relacionados con Anfetaminas/epidemiología , Región de los Apalaches , Estudios Transversales , Femenino , Accesibilidad a los Servicios de Salud/normas , Humanos , Entrevistas como Asunto , Aceptación de la Atención de Salud/etnología , Aceptación de la Atención de Salud/estadística & datos numéricos , Prevalencia , Distribución por Sexo , Centros de Tratamiento de Abuso de Sustancias/estadística & datos numéricos , Tennessee/epidemiología
10.
J Assoc Nurses AIDS Care ; 24(5): 438-48, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23340238

RESUMEN

This paper provides outcomes from an evaluation of a federally funded program combining HIV prevention services with an integrated mental health and substance abuse treatment program to a population of primarily African American ex-offenders living with, or at high risk for contracting HIV in Memphis, Tennessee. During the 5-year evaluation, data were collected from 426 individuals during baseline and 6-month follow-up interviews. A subset of participants (n = 341) completed both interviews. Results suggest that the program was successful in reducing substance use and mental health symptoms but had mixed effects on HIV risk behaviors. These findings are important for refining efforts to use an integrated services approach to decrease (a) the effects of substance use and mental health disorders, (b) the disproportionate impact of criminal justice system involvement, and (c) the HIV infection rate in African American ex-offenders in treatment.


Asunto(s)
Negro o Afroamericano , Criminales , Prestación Integrada de Atención de Salud/organización & administración , Infecciones por VIH/prevención & control , Trastornos Mentales/epidemiología , Trastornos Relacionados con Sustancias/epidemiología , Adulto , Comorbilidad , Continuidad de la Atención al Paciente , Femenino , Estudios de Seguimiento , Humanos , Entrevistas como Asunto , Masculino , Trastornos Mentales/rehabilitación , Trastornos Mentales/terapia , Salud Mental , Persona de Mediana Edad , Modelos Organizacionales , Evaluación de Programas y Proyectos de Salud , Psicoterapia , Calidad de Vida , Asunción de Riesgos , Apoyo Social , Factores Socioeconómicos , Trastornos Relacionados con Sustancias/rehabilitación , Trastornos Relacionados con Sustancias/terapia , Tennessee , Resultado del Tratamiento
12.
J Evid Based Soc Work ; 7(1): 41-57, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20178024

RESUMEN

In the United States, the threat of HIV/AIDS to African American women's health has become the focus of much concern. This paper describes a federally funded community-based program that provides services to African American women at risk for HIV/AIDS in Nashville, Tennessee. The program provides a culturally relevant set of interventions specific to crack cocaine users aimed at reducing substance use and HIV/AIDS risk behaviors. The model is important for the continued development of culturally relevant interventions aimed at reducing the disproportionate rates of HIV/AIDS within the African American community by ensuring treatment access to all populations.


Asunto(s)
Negro o Afroamericano/estadística & datos numéricos , Servicios Comunitarios de Salud Mental/métodos , Promoción de la Salud/métodos , Accesibilidad a los Servicios de Salud , Trastornos Relacionados con Sustancias/rehabilitación , Adolescente , Adulto , Negro o Afroamericano/psicología , Trastornos Relacionados con Cocaína , Cocaína Crack , Femenino , Infecciones por VIH/prevención & control , Humanos , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Evaluación de Programas y Proyectos de Salud , Centros de Tratamiento de Abuso de Sustancias , Trastornos Relacionados con Sustancias/epidemiología , Tennessee/epidemiología , Adulto Joven
13.
Health Soc Work ; 34(4): 283-91, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19927477

RESUMEN

Significant health disparities in the rates of HIV infection primarily affect African American women. Although research has demonstrated that for some individuals HIV is connected to preventable high-risk behaviors related to substance use, a further examination of how these risks are perceived by the individuals involved in these activities is warranted. This study presents the results of 11 focus groups with 89 African American women who use crack cocaine in which respondents shared their perceptions of HIV risk behaviors. The results of this study suggest that women crack cocaine users in Nashville,Tennessee, are not injecting the drug. There appeared to be high levels of perceived sexual risks associated with the use of crack cocaine by some users; however, this was not universal, as many active users have internalized HIV prevention messages. The results of this study are significant in that further understanding of the means by which individuals experience their risk behaviors will enable more effective targeting of potential interventions to reduce the spread of HIV.


Asunto(s)
Negro o Afroamericano , Trastornos Relacionados con Cocaína/complicaciones , Cocaína Crack , Infecciones por VIH/etnología , Infecciones por VIH/etiología , Asunción de Riesgos , Conducta Sexual , Abuso de Sustancias por Vía Intravenosa/complicaciones , Adulto , Femenino , Grupos Focales , Infecciones por VIH/epidemiología , Humanos , Persona de Mediana Edad , Tennessee/epidemiología
14.
J Ethn Subst Abuse ; 7(1): 115-30, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19842304

RESUMEN

Like many areas of the country, the state of Tennessee is experiencing a recent and growing rise in the rate of methamphetamine use, particularly in rural areas of the state. While substance use is a known risk factor for contracting HIV/AIDS, there is limited information regarding the risk behaviors of rural methamphetamine users. This paper seeks to document the existence of known HIV risk behaviors as they relate to rural southern methamphetamine use. Qualitative interviews with ninety-seven current and former methamphetamine users from the Cumberland Plateau area, a rural mountainous region in the state of Tennessee, suggest that methamphetamine users are putting themselves at risk for contracting HIV/AIDS and other blood-borne diseases through high-risk injection and sexual behaviors. Additionally, the results present the perceptions of respondents regarding the impact of methamphetamine use on rural communities and related service needs.


Asunto(s)
Trastornos Relacionados con Anfetaminas/etnología , Actitud Frente a la Salud , Población Negra/psicología , Infecciones por VIH/etnología , Necesidades y Demandas de Servicios de Salud , Indígenas Norteamericanos/psicología , Metanfetamina , Población Rural , Abuso de Sustancias por Vía Intravenosa/etnología , Sexo Inseguro , Población Blanca/psicología , Adulto , Trastornos Relacionados con Anfetaminas/epidemiología , Trastornos Relacionados con Anfetaminas/rehabilitación , Región de los Apalaches/epidemiología , Región de los Apalaches/etnología , Población Negra/estadística & datos numéricos , Estudios Transversales , Femenino , Infecciones por VIH/epidemiología , Infecciones por VIH/transmisión , Encuestas Epidemiológicas , Humanos , Indígenas Norteamericanos/estadística & datos numéricos , Masculino , Metanfetamina/síntesis química , Población Rural/estadística & datos numéricos , Facilitación Social , Factores Socioeconómicos , Abuso de Sustancias por Vía Intravenosa/epidemiología , Abuso de Sustancias por Vía Intravenosa/rehabilitación , Tennessee , Población Blanca/estadística & datos numéricos , Adulto Joven
16.
Am J Drug Alcohol Abuse ; 31(4): 669-84, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16318040

RESUMEN

Despite increasing attention directed to conceptual and methodological issues surrounding spirituality and despite the centrality of "spiritual transformation" in the recovery literature, there is little systematic evidence to support the role of spiritual change as a necessary condition for substance abuse behavior change. As an explicit conceptualization of mechanisms underlying behavior change is fundamental to effective interventions, this article: 1) briefly reviews relevant behavior change theories to identify key variables underlying change; 2) presents an integrative conceptual framework articulating linkages between program components, behavior change processes, spiritual change mechanisms and substance abuse outcomes; and 3) presents a discussion of how the mechanisms identified in our model can be seen in commonly used substance abuse interventions. Overall, we argue that spiritual transformation at an individual level takes place in a social context involving peer influence, role modeling, and social reinforcement.


Asunto(s)
Terapia Conductista , Tratamiento Domiciliario , Espiritualidad , Trastornos Relacionados con Sustancias/prevención & control , Actitud Frente a la Salud , Humanos , Motivación , Religión
17.
J Health Soc Policy ; 20(3): 67-77, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16236679

RESUMEN

This study explores the impact of managed care on the substance abuse service system by reviewing the current status of the programs that were among the elite service providers in 1988. A survey was conducted assessing the status of the one hundred centers touted as the 100 best treatment centers for alcoholism and drug abuse (Sunshine& Wright, 1988). Findings include the following: Almost a third of these centers (31%) are no longer providing services, the majority of the programs who reported data continue to provide services primarily at a residential level of care (92%); however occupancy rates have dropped, the number of annual inpatient admissions have risen, and the length of treatment episodes has significantly decreased. In 1988, almost all (97.5%) facilities adhered to the 28-day treatment regiment, as evidenced by average treatment episodes of 26 days or longer. However, in 2001, the majority of programs (57.5%) reported treatment episodes of 25 days or less. While these facilities represent a fraction of the number of facilities that provide substance abuse services, they do exemplify elite programs that should be insulated from economic troubles, and help to document the changes that have occurred in the delivery system. Awareness of these changes is important for every social worker that advocates for substance abuse services.


Asunto(s)
Alcoholismo , Documentación , Centros de Tratamiento de Abuso de Sustancias/clasificación , Trastornos Relacionados con Sustancias , Alcoholismo/terapia , Recolección de Datos , Humanos , Programas Controlados de Atención en Salud , Centros de Tratamiento de Abuso de Sustancias/economía , Centros de Tratamiento de Abuso de Sustancias/organización & administración , Trastornos Relacionados con Sustancias/terapia , Estados Unidos
18.
J Ethn Subst Abuse ; 4(1): 53-75, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16870572

RESUMEN

Significant health disparities in the rates of HIV infection exist that primarily impact African American women. While research has demonstrated that HIV is preventable through changes in high-risk behaviors facilitated by substance abuse treatment, an individual must first be able to access and engage with treatment to derive any benefit from these services. While there is some research that identifies barriers to treatment access and engagement for African American women who use crack cocaine, these barriers require further examination. Current literature has focused primarily on internal motivation and treatment readiness without placing these concepts within the unique environmental context of social stressors for crack cocaine-using African American women. This study presents the results of eleven focus groups with eighty-nine African American women in which respondents document the HIV risk behaviors of crack cocaine users, present their experiences in accessing substance abuse and HIV services, and documents their perceptions of barriers and services needs. The results of this study may further develop an understanding of the means by which individual service users experience their relationships with service providers and the factors that affect these relationships in order to better target potential interventions to reduce the spread of HIV.


Asunto(s)
Actitud Frente a la Salud/etnología , Negro o Afroamericano/psicología , Trastornos Relacionados con Cocaína/etnología , Cocaína Crack , Infecciones por VIH/etnología , Infecciones por VIH/terapia , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Servicios de Salud Mental/estadística & datos numéricos , Trastornos Relacionados con Sustancias/etnología , Trastornos Relacionados con Sustancias/rehabilitación , Adulto , Negro o Afroamericano/estadística & datos numéricos , Miedo , Femenino , Estado de Salud , Humanos , Prevalencia , Psicología , Centros de Tratamiento de Abuso de Sustancias/estadística & datos numéricos , Encuestas y Cuestionarios , Estados Unidos , Salud de la Mujer
19.
J Addict Dis ; 23(4): 41-53, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15339713

RESUMEN

A structured diagnostic interview (Practical Adolescent Diagnostic Interview) designed to gather basic information about substance use disorders, other mental health conditions, and related experiences was used in a variety of clinical settings. Anonymous data from 279 adolescents interviewed as part of routine clinical assessments in a variety of clinical programs were analyzed to assess the ability of the questions to identify potential problem areas and to provide a preliminary exploration of interrelationships between those problems. Results demonstrated that the vast majority of individuals manifested indications of multiple problems. For a given diagnostic condition, the trend is for those meeting at least the minimal DSM-IV criteria to exhibit substantially more than the minimum number of symptoms. Internal consistencies for item groups defining the various conditions range from more than .700 to over .900 indicating adequate to excellent internal consistency and reliability. Utility of the instrument for routine clinical use is also discussed.


Asunto(s)
Psiquiatría del Adolescente/métodos , Entrevista Psicológica , Adolescente , Conducta del Adolescente , Niño , Diagnóstico Diferencial , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Femenino , Humanos , Masculino , Psicometría , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
20.
Soc Work ; 49(3): 356-63, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15281690

RESUMEN

This article provides information on harm reduction, a recent development in substance abuse services in response to the HIV/AIDS epidemic. The author outlines abstinence and harm reduction perspectives and the stages of change model and discusses how these perspectives can be integrated in social work practice. He proposes using harm reduction strategies for individuals for whom the abstinence perspective may not be appropriate. Together, the traditional abstinence and harm reduction perspectives provide a basis for a more comprehensive continuum of care for individuals experiencing problems related to their substance use.


Asunto(s)
Reducción del Daño , Servicio Social , Trastornos Relacionados con Sustancias/terapia , Humanos , Trastornos Relacionados con Sustancias/prevención & control , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA